Cipla Ltd. is in Pharmaceuticals & Drugs. It was incorporated in year 1935. The current market capitalisation stands Rs 34520 Cr. The company is listed on the Bombay Stock Exchange (BSE) with the BSE code as 500087. and also listed on National Stock Exchange (NSE) with NSE code as CIPLA.
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India. It offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as women’s health, cardiovascular, children’s health, dermatology and cosmeceuticals, diabetes, HIV-AIDS, hepatitis, oncology, infectious diseases and critical care, malaria, neurosciences, ophthalmology, osteoporosis, respiratory, and urology. The also provides inhalation therapy devices comprising metered-dose inhalers, dry powder inhalers, nasal sprays, nebulizers, and inhalation accessory devices, as well as spacers and related devices. In addition, it exports its products to Africa, the Middle East, Latin America, Asia, North America, Australia, New Zealand, Russia, and internationally. Cipla Limited was founded in 1935 and is based in Mumbai, India.